STATFatty liver disease was alleviated by Lilly's 'triple-G' obesity drugJun 26, 2023Elaine ChenBy Elaine Chenmore_vert
Investors | Eli Lilly and CompanyLilly's phase 2 retatrutide results published in The New England Journal of Medicine show the investigational molecule ...Jun 26, 2023more_vert
MedscapeNew Oral GLP-1 Agonist for Obesity, Type 2 DiabetesJun 24, 2023Miriam E. TuckerBy Miriam E. Tuckermore_vert
NBC NewsExperimental drug could offer more weight loss than any drug now on the market, study findsJun 26, 2023Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert
Business WireData shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma ...Jun 23, 2023more_vert
Investors | Eli Lilly and CompanyLilly's phase 2 results published in the New England Journal of Medicine show orforglipron, a once-daily oral ...Jun 23, 2023more_vert
STATOzempic 3.0? New weight loss drug from Lilly shows promise in Phase 2 trialJun 26, 2023Elaine ChenBy Elaine Chenmore_vert